Medical robotics Increasing prevalence of chronic diseases had uplift the market growth and is expected to grow at a CAGR of 15.69% during forecast period; asserts MRFR Unleashing Industry Forecast

The medical robotics market is estimated to register a CAGR of 15.69% during the forecast period of 2023 to 2032.

MRFR recognizes the following companies as the key players in the global medical robotics market— Auris Health Inc. (US), Medtronic (Ireland), Zimmer Biomet (US), Renishaw Plc. (UK), Health Robotics S.R.L (Europe), Stryker (US), Smith+Nephew (UK), Intuitive Surgical (US), KUKA AG (Germany), and CMR Surgical (UK).

Market Highlights

The global medical robotics market is expected to register a CAGR of 15.69% during the forecast period and is estimated to reach USD 52.41 billion by 2032.

Medical robotics is a technology used in the healthcare industry to aid healthcare professionals to diagnose and treat diseases that correct, restore, or modify bodily functions. It allows surgeons to carry out operations more precisely and in a less invasive way. It increases the preciseness of the operation with a wide range of advantages such as the decreased risk of infection, decreased post-operative pain, and possess fewer life risks.

Growing applications of medical robotics is one of the major factors driving the growth of the global medical robotics market. Likewise, technological advancements and increasing strategic initiatives are further fueling the growth of the global market during the review period. However, the high cost of robots is expected to hamper the growth of the global market. Nevertheless, the increasing demand for automation is anticipated to create lucrative opportunities for the players operating in the global market.

Segment Analysis

The global medical robotics market has been segmented based on type, product, application, setting, and end user.

On the basis of type, the market is segmented into equipment, service, and consumables. The equipment segment held the majority share in the market in 2022. The rise in geriatric population and the technological advancements helps this segment to grow further.

Based on product, the global medical robotics market has been segmented into surgical robots, rehabilitation robots, noninvasive radiosurgery robots, hospital & pharmacy robots, emergency response robotic systems, logistics/handling robotic systems, imaging robotic systems. The surgical robots segment is further divided into soft tissue surgery, hard tissue surgery, and micro surgery. Furthermore, the rehabilitation robots segment is further divided into assistive robots, prosthetics, orthotics, therapeutic robots, and exoskeleton robotic systems. Moreover, the hospital and pharmacy robots are further divided into telemedicine robots, I.V. robots, pharmacy robots, and cart transportation robots.

The rehabilitation robots segment dominated the market in 2022. Rehabilitation robots augment patient rehabilitation through the application of robotic devices. It allows patients to practice movements aided by the robot. In recent years, there has been a rapid and vast development of robots for the rehabilitation of sensorimotor deficits after damage to the central nervous system (CNS). For instance, in December 2021, Inrobics Social Robotics launched AI-based robotic device to improve health rehabilitation. The growing technological advancements and increasing adoption of medical robotics in dental surgeries helps the segment to propel.

On the basis of the application, the market is segmented into neurology, oncology, orthopedic, laparoscopy, cardiology, aesthetic surgery, rehabilitation, angiography, and others. The oncology segment is further divided into breast cancer, intraoperative radiation therapy, and others. Moreover, the orthopedic segment is further bifurcated into non-contact bone cutting and bone surgery and others. The laparoscopy segment held the largest market share in 2022. Laparoscopic devices are proved to be effective tools for diagnostic and therapeutic purposes. The rise in funding and reimbursement framework has been observed in laparoscopy-assisted surgeries.

Based on setting, the global medical robotics market has been segmented into homecare, in-patient, and out-patient. The out-patient segment dominated the market in 2022. There’s increasing adoption of surgical robotics in outpatient settings owing to its several benefits such as immediate treatment.

Based on end user, the global medical robotics market has been segmented into hospital & clinics, specialty centers, rehabilitation centers, and others. The hospital & clinics segment dominated the market in 2022. Hospitals & clinics are increasingly adopting new and advanced technologies for various procedures such as coronary artery bypass, cancer related surgeries, gallbladder removal, hip replacement, hysterectomy, total or partial kidney removal, kidney transplant, and others. Adoption of such devices provides competitive advantages to those hospitals and clinics. Moreover, increasing consumer awareness of advanced treatment procedures is also driving the market for medical robotics in hospitals & clinics.

Access full report @ https://www.marketresearchfuture.com/reports/medical-robotics-market-1311

Regional Analysis

The global medical robotics market, based on region, has been divided into North America, Europe, Asia-Pacific, and Rest of the World. North America consists of US and Canada. The Europe medical robotics market comprises of Germany, France, the UK, Italy, Spain, and the rest of Europe. The medical robotics market in Asia-Pacific has been segmented into China, India, Japan, Australia, South Korea, and the rest of Asia-Pacific. The Rest of the World medical robotics market comprises of Middle East, Africa, and Latin America.

The major factors that are attributed to its increasing demand for advanced surgical robots, an increasing number of patients undergoing minimally invasive surgical procedures, and the presence of a large number of market players in the region. For instance, in 2020, Accuray Incorporated (US) launched CyberKnife S7 System a next-generation CyberKnife platform with advanced precision, and real-time artificial intelligence (AI)-driven motion tracking and synchronization treatment delivery for all Stereotactic Radiosurgery (SRS) and Stereotactic Body Radiation Therapy (SBRT) treatments. Additionally, the increasing prevalence of chronic diseases, coupled with a higher number of patients suffering from neurological disorders, are driving the market demand for surgical, and other robots in North America.

The increasing geriatric population in the developed countries and the globalization of healthcare is increasing the demand for medical robots in Europe. In addition, the UK is populated by the elderly population and has developed several medical robots to help with the initial onset of dementia and help the geriatric population. Factors such as greater precision and safer surgical procedures provided by medical robots are also gaining ground, possibly leading to the growth of the medical robotics industry across the European region.

In addition, increasing funds from public and private organizations and individuals directly supports the growth of the medical robotics market. For instance, in 2020, Medtronic (Ireland) acquired Medicrea, a pioneer in the transformation of spinal surgery through artificial intelligence, predictive modeling, and patient-specific implants. This acquisition has helped Medtronic to strengthen its position as a global innovator in enabling technologies and solutions for spine surgery. Moreover, the rise in the demand for minimally invasive and non-invasive surgical procedures are the major factors driving the market growth in the Asia-Pacific region.

Furthermore, the growing prevalence of cardiovascular and orthopedic diseases with an increasing advancement in technology in pharma are the major factors driving the growth of the market in the Middle East and Africa. In addition, an increase in advancement in technology and devices is helping to boost cost-effective treatments and medications by medical robots.  

Key Findings of the Study

• The global medical robotics market is expected to reach USD 52.41 billion by 2032, at a CAGR of 15.69% during the forecast period.


• The Asia-Pacific region accounted for the fastest-growing global market.


• Based on type, the equipment segment was attributed to holding the largest market in 2022.


• Zimmer Biomet (US), Stryker (US), Medtronic (Ireland), Smith+Nephew (UK), and Intuitive Surgical (US) are the key market players.